Warby Parker (NYSE: WRBY) co-founder plans 80,094-share stock sale

Rhea-AI Filing Summary

Warby Parker co-founder David Gilboa has filed a Form 144 indicating an intention to sell 80,094 shares of common stock. The planned sale, through Morgan Stanley Smith Barney LLC on the NYSE, covers shares with an aggregate market value of $2,128,898.52, with 105,727,103 common shares stated as outstanding and an approximate sale date of January 13, 2026. The shares to be sold were acquired on June 28, 2017 through previously exercised options and restricted stock units, paid in cash.

The filing also lists recent Rule 10b5-1 trading activity for Gilboa over the prior three months, including sales such as 200,000 common shares on December 11, 2025 for gross proceeds of $6,040,800.00 and 75,000 shares on January 7, 2026 for $2,031,375.00. Additional transactions include 50,000 common shares sold by the David Gilboa Charitable Fund on December 23, 2025 for $1,298,345.00 and several other 10b5-1 sales in late 2025 and early 2026.

Insights

Equity analyst – insider activity

Form 144 shows planned and recent 10b5-1 sales by Warby Parker co-founder David Gilboa.

The notice reports that 80,094 common shares of Warby Parker are intended to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $2,128,898.52. These shares were acquired on June 28, 2017 via previously exercised options and restricted stock units, with cash payment noted.

The filing also details multiple Rule 10b5-1 sales over the prior three months for David Gilboa and an affiliated charitable fund. Examples include 200,000 common shares sold on December 11, 2025 for gross proceeds of $6,040,800.00 and 75,000 shares on January 7, 2026 for $2,031,375.00. Because the transactions are tied to 10b5-1 arrangements, they appear to be conducted under pre-established trading instructions rather than ad hoc discretionary trades.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	80094	2128898.52	105727103	01/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/28/2017	Previously Exercised Options and Restricted Stock Units	Issuer			80094	06/28/2017	Cash and N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DAVID GILBOA 233 Spring Street, 6th Floor East New York NY 10013	Common	01/09/2026	19906	578981.93
10b5-1 Sales for DAVID GILBOA 233 Spring Street, 6th Floor East New York NY 10013	Common	01/07/2026	75000	2031375.00
10b5-1 Sales for DAVID GILBOA 233 Spring Street, 6th Floor East New York NY 10013	Common	01/06/2026	50000	1214560.00
10b5-1 Sales for DAVID GILBOA 233 Spring Street, 6th Floor East New York NY 10013	Common	01/02/2026	25000	561585.00
David Gilboa Chartiable Fund 233 Spring Street 6th Floor East New York NY 10013	Common	12/23/2025	50000	1298345.00
10b5-1 Sales for DAVID GILBOA 233 Spring Street, 6th Floor East New York NY 10013	COMMON	12/11/2025	200000	6040800.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the WRBY Form 144 filing by David Gilboa disclose?

The Form 144 filing discloses that David Gilboa, a co-founder of Warby Parker, intends to sell 80,094 shares of the company’s common stock. The filing specifies that the planned sale will be executed through Morgan Stanley Smith Barney LLC on the NYSE, and indicates an aggregate market value of $2,128,898.52 for the shares to be sold.

How many Warby Parker (WRBY) shares are planned to be sold and at what stated value?

The notice states that 80,094 common shares are to be sold, with an aggregate market value of $2,128,898.52. These shares are part of the issuer’s total of 105,727,103 common shares outstanding referenced in the filing.

When were the WRBY shares in the Form 144 acquired and how?

The shares covered by the Form 144 were acquired on June 28, 2017. The filing describes the acquisition as “Previously Exercised Options and Restricted Stock Units”, with the nature of payment listed as cash (and “N/A” for any non-cash component).

What recent 10b5-1 sales by David Gilboa related to WRBY stock are listed?

The filing lists several Rule 10b5-1 sales in the past three months, including: 200,000 common shares sold on December 11, 2025 for $6,040,800.00, 75,000 shares on January 7, 2026 for $2,031,375.00, 50,000 shares on January 6, 2026 for $1,214,560.00, and 25,000 shares on January 2, 2026 for $561,585.00.

Does the WRBY Form 144 mention any sales by a charitable fund associated with David Gilboa?

Yes. The filing shows a transaction for David Gilboa Charitable Fund, at the same listed address, selling 50,000 common shares on December 23, 2025 for $1,298,345.00 in gross proceeds.

What representation does the selling person make in the WRBY Form 144?

The person for whose account the securities are to be sold represents by signing that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. For transactions relying on Rule 10b5-1, this representation is made as of the plan adoption or instruction date.